Literature DB >> 8058108

Functional relation between nitric oxide and noradrenaline for the modulation of vascular tone in rat mesenteric vasculature.

R Yamamoto1, A Wada, Y Asada, T Yuhi, T Yanagita, H Niina, A Sumiyoshi.   

Abstract

As previously reported, N omega-nitro-L-arginine (L-NNA), an inhibitor of nitric oxide (NO) synthesis, decreased transmural field stimulation (TFS)-induced noradrenaline overflow from the isolated perfused rat mesenteric vasculature attached to the intestine. The decrease was attenuated by L-arginine. This suggests that NO may increase noradrenaline release (Yamamoto et al. 1993). The present experiments with this preparation were done in order to monitor changes in vascular perfusion pressure caused by TFS or by noradrenaline infusion in parallel with those in the noradrenaline outflow caused by TFS in the presence of atropine (0.1 mumol/l) (to block acetylcholine-induced release of endothelial NO) and of indomethacin (3 mumol/l) (to inhibit L-NNA-induced production of vasoconstrictor prostanoids). (1) TFS (2-10 Hz) caused a frequency-dependent increase in noradrenaline overflow and perfusion pressure. (2) L-NNA (10 and 30 mumol/l) caused a concentration-dependent inhibition of TFS-induced noradrenaline overflow, whereas the TFS-induced pressure increase was augmented by L-NNA in a concentration-dependent manner. At any given concentration of L-NNA, the potentiation of vasoconstriction by L-NNA became greater in magnitude as the frequency of the TFS was raised. (3) Infusion of noradrenaline (0.38-6 nmol) caused a dose-dependent increase in perfusion pressure up to a value comparable with that caused by TFS. The pressure increase in response to noradrenaline infusion was also enhanced by L-NNA, relatively, to a greater extent than the enhancement, by L-NNA, of the pressure response to TFS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058108     DOI: 10.1007/bf00170881

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

Review 1.  Nitric oxidergic neurogenic vasodilation in the porcine basilar artery.

Authors:  T J Lee; S J Sarwinski
Journal:  Blood Vessels       Date:  1991

2.  Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery.

Authors:  R A Cohen; R M Weisbrod
Journal:  Am J Physiol       Date:  1988-05

3.  Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: implications for endotoxin shock.

Authors:  C Gonzalez; A Fernandez; C Martin; S Moncada; C Estrada
Journal:  Biochem Biophys Res Commun       Date:  1992-07-15       Impact factor: 3.575

4.  Endothelial alpha 2-adrenoceptors in canine pulmonary and systemic blood vessels.

Authors:  V M Miller; P M Vanhoutte
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

5.  Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.

Authors:  E A Kowaluk; P Seth; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1992-09       Impact factor: 4.030

6.  Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery.

Authors:  P A Vo; J J Reid; M J Rand
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

7.  Role of nitric oxide from the endothelium on the neurogenic contractile responses of rabbit pulmonary artery.

Authors:  K Shinozuka; Y Kobayashi; K Shimoura; K Hattori
Journal:  Eur J Pharmacol       Date:  1992-11-03       Impact factor: 4.432

8.  Mechanism of neurally induced monkey mesenteric artery relaxation and contraction.

Authors:  N Toda; T Okamura
Journal:  Hypertension       Date:  1992-02       Impact factor: 10.190

9.  Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter.

Authors:  H Bult; G E Boeckxstaens; P A Pelckmans; F H Jordaens; Y M Van Maercke; A G Herman
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

10.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

Authors:  R M Palmer; D D Rees; D S Ashton; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

View more
  6 in total

1.  Large- and small-conductance Ca(2+)-activated K+ channels: their role in the nicotinic receptor-mediated catecholamine secretion in bovine adrenal medulla.

Authors:  A Wada; M Urabe; T Yuhi; R Yamamoto; T Yanagita; H Niina; H Kobayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

2.  Chronic blockade of nitric oxide synthesis elevates plasma levels of catecholamines and their metabolites at rest and during stress in rats.

Authors:  R Kvetnanský; K Pacák; D Tokarev; J Jeloková; D Jezová; M Rusnák
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

Review 3.  Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.

Authors:  H Macarthur; G H Wilken; T C Westfall; L L Kolo
Journal:  Acta Physiol (Oxf)       Date:  2011-03-01       Impact factor: 6.311

4.  An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition.

Authors:  Noel Yan-Ki Chan; Nahid Seyedi; Kenichi Takano; Roberto Levi
Journal:  Circulation       Date:  2011-12-09       Impact factor: 29.690

5.  Nitric oxide inhibition and the impact on renal nerve-mediated antinatriuresis and antidiuresis in the anaesthetized rat.

Authors:  N M Bagnall; P C Dent; A Walkowska; J Sadowski; E J Johns
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

Review 6.  Role of Nitric Oxide in the Cardiovascular and Renal Systems.

Authors:  Ashfaq Ahmad; Sara K Dempsey; Zdravka Daneva; Maleeha Azam; Ningjun Li; Pin-Lan Li; Joseph K Ritter
Journal:  Int J Mol Sci       Date:  2018-09-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.